Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-24-017159

Options or other derivatives

  • PRESIDENT & CEO acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marucci Anthony S PRESIDENT & CEO 2024-06-13 Grant or award · Incentive Stock Option (right to buy) +300,000 300,000 D
Loading xslF345X05/form4-06172024_080622.xml…